Baqsimi 3 MG spray two packs
Ended Awarded Last action
- Contract number
- SPE2DR26F9JYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,301
Award facts
- Contract value 100% obligated
- $10,300.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,300.68 delivery order to AmerisourceBergen Drug Corp on April 17, 2026, for BAQSIMI 3 mg spray two-packs, with ultimate completion on April 20, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor for the Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9JYL?
SPE2DR26F9JYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 17, 2026.
How much is contract SPE2DR26F9JYL worth?
The government has obligated $10,301 on SPE2DR26F9JYL.
Is contract SPE2DR26F9JYL an order under another contract?
Yes. SPE2DR26F9JYL is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9JYL competed?
The extent of competition for SPE2DR26F9JYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award